Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation

Marika Milan1, Valentina Pace1, Fabio Maiullari1,2

  • 1Institute of Cell Biology and Neurobiology (IBCN), National Research Council of Italy (CNR), Monterotondo Scalo, Rome, 00015, Italy.

Cell Death & Disease
|January 27, 2018
PubMed

Insights

Histone deacetylase inhibitor Givinostat reduced cardiac fibrosis and improved heart function in a mouse model of myocardial infarction. This epigenetic therapy shows promise for treating cardiovascular diseases (CVDs).

Area of Science:

  • Cardiovascular Research
  • Epigenetics
  • Pharmacology

Background:

  • Cardiovascular diseases (CVDs) represent a significant global health burden, with heart failure as a common outcome.
  • Current treatments struggle to halt the structural changes leading to heart failure.
  • Epigenetics, particularly histone modifications, plays a role in CVDs, but therapeutic interventions are limited.

Purpose of the Study:

  • To investigate the therapeutic potential of the histone deacetylase inhibitor, Givinostat, in a mouse model of acute myocardial infarction.
  • To elucidate the mechanisms by which Givinostat impacts cardiac tissue and vascular function post-myocardial infarction.

Main Methods:

  • Utilized a mouse model of acute myocardial infarction.
  • Administered the histone deacetylase inhibitor, Givinostat.
  • Assessed changes in endothelial-to-mesenchymal transition, inflammation, cardiac fibrosis, vascular apoptosis, and cardiac performance.

Main Results:

  • Givinostat treatment decreased endothelial-to-mesenchymal transition and inflammation.
  • The drug reduced cardiac fibrosis and improved overall heart performance.
  • Givinostat protected blood vessels from apoptosis via modulation of cardiac fibroblasts on endothelial cells.

Conclusions:

  • Givinostat demonstrates a protective effect in a mouse model of myocardial infarction.
  • The drug's mechanisms involve reducing fibrosis, inflammation, and vascular apoptosis.
  • Givinostat shows potential as a novel therapeutic agent for cardiovascular diseases.

Related Concept Videos

Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
11.3K
Enteric Nervous System: Regulation of GI Motor Activity01:11

Enteric Nervous System: Regulation of GI Motor Activity

The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
1.9K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.7K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.5K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.3K